The LEO Foundation Award – Region EMEA 2025
Grantee: Dr. Thierry Nordmann, Dr. med., Dr. phil. nat., Max Planck Institute of Biochemistry, Germany
Amount: USD 100,000
Grant category: LEO Foundation Awards
Year: 2025
Geography: Germany
Dr. Thierry Nordmann is a Senior Physician at the University Hospital of Ludwig Maximilian, Munich, and Group Leader at the Max Planck Institute of Biochemistry in Martinsried.
He received the LEO Foundation Award 2025 in Region EMEA during the ESDR annual meeting in Antwerp. Dr. Thierry Nordmann is recognized for his excellent research and innovative vision, aiming to transform the future understanding, diagnosis and treatment of inflammatory skin diseases.
The LEO Foundation Award – worth USD 100,000 – recognizes outstanding young researchers and scientists from around the world whose work represents an extraordinary contribution to skin research and has the potential to pave the way for new and improved treatments for skin diseases.
The LEO Foundation Award 2015 – Silver Award
Grantee: Dr. Kilian Eyerich
Amount: DKK 500,000
Grant category: LEO Foundation Awards
Year: 2015
Geography: Germany
Presented to Dr. Kilian Eyerich, Assistant Professor, Experimental Dermato-Immunology, School of Medicine, Technische Universität München, Germany.
Early in his career, Dr. Eyerich studied the cross-talk between keratinocytes and T cells usingco-cultures.His work on the role of Th17 and Th22 cells in the skin has significantly enhanced molecular understanding of atopic dermatitis and psoriasis. Dr. Eyerich has identified a unique group of patients with co-existing inflammatory skin diseases and demonstrated the mutual antagonism of T cells causing atopic dermatitis and psoriasis.
The LEO Foundation Award 2014 – Silver Award
Grantee: Dr. Christina Zielinski
Amount: DKK 500,000
Grant category: LEO Foundation Awards
Year: 2014
Geography: Germany
Presented to Dr. med. Christina Zielinski, research group leader and dermatological fellow, Department of Dermatology and Allergology and Berlin-Brandenburg Center for Regenerative Therapies, Charité University Medicine, Berlin.
Dr. Zielinski’s research focuses on how the body’s immune system protects itself from microbial assault by distinguishing between the body’s own cells and foreign organisms. It examines what happens when the body does not regulate itself in this way and how this affects the development of autoimmune diseases such as psoriasis and multiple sclerosis. Insights gained from these studies are expected to identify molecular cues that can be exploited in order to develop immune modulation therapies.